Obesity as a Risk Factor Against COVID-19

Rosa Elvira Minchala Urgilés; Anabel Estefanía Arce Prieto; Andrés Alexis Ramírez Coronel; Lilia Romero Sacoto; Fanny González León; María De Los Ángeles Estrella-González; Pedro Carlos Martínez-Suárez

doi:doi:10.11648/j.sjcm.20211002.13

Obesity as a Risk Factor Against COVID-19

Rosa Elvira Minchala Urgilés, Anabel Estefanía Arce Prieto, Andrés Alexis Ramírez Coronel, Lilia Romero Sacoto, Fanny González León, María De Los Ángeles Estrella-González, Pedro Carlos Martínez-Suárez

Published in Science Journal of Clinical Medicine (Volume 10, Issue 2)

Received: 22 April 2021 Accepted: 21 May 2021 Published: 31 May 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

In late 2019, in Wuhan City, China, SARS-CoV2 was identified as the cause of an outbreak of acute respiratory illness called COVID-19 representing its most frequent lethal complication. Objective: To analyze, by means of a literature review, obesity as a risk factor for COVID-19. Methodology: A systematic review of the literature was carried out in scientific databases such as: Latin American and Caribbean Health Sciences Literature (LILACS); Virtual Health Library (VHL): Wiley Online Library and Medical Literature Analysis and Retrieval System Online (MEDLINE), Scielo, Scopus. The search terms included the study variables. Results: According to the analysis of 51 articles, it was determined that obese, male and elderly patients are the profile most prone to present respiratory system failures associated with COVID-19. Their pictures are aggravated by immunological and hormonal physiopathology typical of obesity; in addition, comorbidity in which there is diabetes, hypertension, cardiovascular diseases and obstructive pulmonary disease aggravates the picture of COVID-19 in obese patients. Conclusions: The presence of obesity is indeed a risk factor against COVID-19 infection, since it increases the possibility of suffering severe respiratory conditions.

Published in	Science Journal of Clinical Medicine (Volume 10, Issue 2)
DOI	10.11648/j.sjcm.20211002.13
Page(s)	30-37
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

COVID-19, Obesity, Risk Factors, Comorbidity

References

[1]	WHO. WHO \| Obesity. WHO [Internet]. 2016 [cited 2021 Mar 25]; Available from: http://www.who.int/topics/obesity/es/
[2]	OPS. Coronavirus (COVID-19) events as they happen [Internet]. WORLD HEALTH ORGANITATION. 2020 [cited 2021 Mar 25]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen
[3]	Clemmensen C, Petersen M, Sørensen A. Will the COVID-19 pandemic worsen the obesity epidemic? comment [Internet]. 2020; 16. Available from: https://www.
[4]	Cai Q, Chen F, Wang T, Luo F, Liu X, Wu Q, et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care. 2020; 43 (7): 1392–8.
[5]	Sattar N, McInnes IB, McMurray JJV. Obesity Is a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms. Circulation. 2020; 44 (0): 4-6.
[6]	Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F, et al. Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission [Internet]. Vol. 71, Clinical Infectious Diseases. Oxford University Press; 2020 [cited 2021 Mar 25]. p. 896–7. Available from: https://academic.oup.com/cid/article/71/15/896/5818333
[7]	Petrilli C, Jones S, Yang J, Rajagopalan H, O'Donnell L, Chernyak Y, et al. Factors associated with hospitalization and critical illness among 4,103 patients with Covid-19 disease in New York City. medRxiv. 2020; (646): 1–25.
[8]	Gao F, Zheng KI, Wang XB, Sun QF, Pan KH, Wang TY, et al. Obesity Is a Risk Factor for Greater COVID-19 Severity. Diabetes Care. 2020; 43 (7): E72–4.
[9]	Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018 Key findings Data from the National Health and Nutrition Examination Survey [Internet]. 2017 [cited 2021 Mar 25]. Available from: https://www.cdc.gov/nchs/products/index.htm.
[10]	Marques A, Peralta M, Naia A, Loureiro N, De Matos MG. Prevalence of adultoverweight and obesity in 20 European countries, 2014. Eur J Public Health. 2018; 28 (2): 295–300.
[11]	González-Muniesa P, Mártinez-González MA, Hu FB, Després JP, Matsuzawa Y, Loos RJF, et al. Obesity. Nat Rev Dis Prim. 2017; 3.
[12]	Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020; 109 (5): 531–8.
[13]	Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obesity. 2020; 28 (7): 1195-9.
[14]	Xiang T, Liu J XF. Analysis of clinical characteristics of 49 patients with coronavirus disease 2019 in Jiangxi [Internet]. Epistemonics. 2020 [cited 2021 Mar 25]. Available from: https://www.epistemonikos.org/documents/dbcd5d8a417acff834a4a01e025657387fc1159f
[15]	EL-Arabey AA, Abdalla M. Metformin and COVID-19: A novel deal of an old drug. J Med Virol. 2020; 92 (11): 2293–4.
[16]	Health E for public, Istituto Superiore di Sanità. Characteristics of SARS-CoV-2 patients dying in Italy Report. ISTITVTO SVPERIORE DI SANITA [Internet]. 2020; 4–8. Available from: https://www.epicentro.iss.it/en/coronavirus/sars-cov-2-analysis-of-deaths%0A https://www.epicentro.iss.it/en/coronavirus/bollettino/Report -COVID-2019_7_september_2020.pdf
[17]	Campoverde ME, Añez R, Salazar J, Rojas J, Bermúdez V. Risk factors for obesity in adults from the city of Cuenca, Ecuador. Rev Latinoam Hipertens. 2016; 9 (3): 1–10.
[18]	Di Angelantonio E, Bhupathiraju SN, Wormser D, Gao P, Kaptoge S, de Gonzalez AB, et al. Body-mass index and all-cause mortality: individual-participant-datameta-analysis of 239 prospective studies in four continents. Lancet. 2016; 388 (10046): 776-86.
[19]	Secretan BL, Ph D, Scoccianti C, Ph D, Loomis D, Ph D. Spe ci al R ep or t Body Fatness and Cancer - Viewpoint of the IARC Working Group. Med Spec. 2016; (Copyright): 794–8.
[20]	Dietz W, Santos-Burgoa C. Obesity and its Implications for COVID-19 Mortality. Obesity. 2020; 28 (6): 1005.
[21]	Pinazo-hernandis S. DAD E SPA AT Y GER ON TO Psychosocial impact of COVID-19 on older people: problems and challenges Psychosocial impact of COVID-19 on older people: Problems and challenges. Rev Esp Geriatr Gerontol [Internet]. 2020; 55 (5): 249–52. Available from: https://doi.org/10.1016/j.regg.2020.05.006
[22]	Hussain A, Mahawar K, Xia Z, Yang W, EL-Hasani S. Obesity and mortality of COVID-19. Meta-analysis. Obes Res Clin Pract [Internet]. 2020; 14 (4): 295–300. Available from: https://doi.org/10.1016/j.orcp.2020.07.002
[23]	Muscogiuri G, Pugliese G, Barrea L, Savastano S, Colao A. Commentary: Obesity: The & quot; Achilles heel & quot; for COVID-19? Metabolism [Internet]. 2020; 108 (January): 154251. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32353356%0A http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC7184987
[24]	Peres IT, Bastos LSL, Gelli JGM, Marchesi JF, Dantas LF, Antunes BBP. Since January 2020 Elsevier has created a COVID-19 resource center with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource center is hosted on Elsevier Connect, the company 's public news and information. Public Health. 2020; (January).
[25]	Frühbeck G, Busetto L, Dicker D, Yumuk V, Goossens GH, Hebebrand J, et al. The ABCD of obesity: An EASO position statement on a diagnostic term with clinical and scientific implications. Obes Facts. 2019; 12 (2): 131–6.
[26]	Global Health. The Sex, Gender and COVID-19 Project \| Global Health 50/50 [Internet]. March. 2021 [cited 2021 Mar 25]. Available from: https://globalhealth5050.org/the-sex-gender-and-covid-19-project/
[27]	Davies NG, Klepac P, Liu Y, Prem K, Jit M, Eggo RM, et al. Age-dependent effects in the transmission and control of COVID-19 epidemics. medRxiv. 2020.
[28]	Chen Y, Klein SL, Garibaldi BT, Li H, Wu C, Osevala NM, et al. Aging in COVID-19: Vulnerability, immunity and intervention. Aging Res Rev. 2021; 65 (January).
[29]	Wensveen FM, Valentić S, Šestan M, Turk Wensveen T, Polić B. The “Big Bang” in obese fat: Events initiating obesity-induced adipose tissue inflammation. Eur J Immunol. 2017; 45 (9): 2446–56.
[30]	Belančić A, Kresović A, Rački V. Potential pathophysiological mechanisms leading to increased COVID-19 susceptibility and severity in obesity. Obes Med [Internet]. 2020; 19 (May): 100259. Available from: https://doi.org/10.1016/j.obmed.2020.100259
[31]	Lee-Cervantes DE, Sánchez-Jiménez BA, Gutiérrez-Grobe Y, Yeverino-Suárez P, Juárez-Hernández E, Chávez-Tapia NC. Clinical effect of obesity in the treatment of abdominal pain in the emergency department. Med Interna Mex. 2016; 30 (5): 546–53.
[32]	Ahn SY, Sohn SH, Lee SY, Park HL, Park YW, Kim H, et al. The effect of lipopolysaccharide-induced obesity and its chronic inflammation on influenza virus-related pathology. Environ Toxicol Pharmacol [Internet]. 2015; 40 (3): 924–30. Available from: http://dx.doi.org/10.1016/j.etap.2015.09.020
[33]	Alves A, Quispe A, Ávila A, Valdivia A, Chino J, Vera O. Brief history and pathophysiology of COVID-19. Diagnostic Guide and COVID-19 Treatment in Ter Intensive Units for Boliv [Internet]. 2020; 61 (1): 77–86. Available from: http://www.scielo.org.bo/scielo.php?pid=S1652-67762020000100011&script=sci_arttext
[34]	Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet [Internet]. 2021; 6736 (21): 1-12. Available from: http:///dx.doi.org/10.1016/S0140-6736(21)00306-8
[35]	Kass DA, Duggal P, Cingolani O. Obesity could shift severe COVID-19 disease to younger ages. Lancet [Internet]. 2020; 395 (10236): 1544-5. Available from: http:///dx.doi.org/10.1016/S0140-6736(20)31024-2
[36]	Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet [Internet]. 2020; 395 (10229): 1054-62. Available from: http:///dx.doi.org/10.1016/S0140-6736 (20) 30566-3
[37]	Mehanna O, Askary A El, Ali E, Esawy B El, Fathalla T, Gharib AF. Impact of obesity and its associated comorbid conditions on COVID-19 presentation. Diabetes, Metab Syndr Obes Targets Ther. 2021; 14: 409-15.
[38]	Afolabi HA, Zakariya Z bin, Ahmed Shokri A Bin, Mohammad Hasim MN Bin, Vinayak R, Afolabi-Owolabi OT, et al. The relationship between obesity and other medical comorbidities. Obes Med [Internet]. 2020; 17 (November 2019): 100164. Available from: https://doi.org/10.1016/j.obmed.2019.100164
[39]	Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19. Aging (Albany NY). 2020; 12 (7): 6049-57.
[40]	Goossens GH. The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function. Obes Facts. 2017; 10 (3): 207–15.
[41]	Cândido FG, Valente FX, Grześkowiak ŁM, Moreira APB, Rocha DMUP, Alfenas R de CG. Impact of dietary fat on gut microbiota and low-grade systemic inflammation: mechanisms and clinical implications on obesity. Int J Food Sci Nutr [Internet]. 2018; 69 (2): 125–43. Available from: https://doi.org/10.1080/09637486.2017.1343286
[42]	Al-Benna S. Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients. Obes Med [Internet]. 2020; 19 (July): 100283. Available from: https://doi.org/10.1016/j.obmed.2020.100283
[43]	Bourgonje AR, Abdulle AE, Timens W, Hillebrands JL, Navis GJ, Gordijn SJ, et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol. 2020; 251 (3): 228-48.
[44]	Bello-Chavolla OY, González-Díaz A, Antonio-Villa NE, Fermín-Martínez CA, Márquez-Salinas A, Vargas-Vázquez A, et al. Unequal Impact of Structural Health Determinants and Comorbidity on COVID-19 Severity and Lethality in Older Mexican Adults: Considerations Beyond Chronological Aging. Journals Gerontol Ser A. 2020; 76 (3): 52–9.
[45]	Upadhyay J, Farr O, Perakakis N, Ghaly W, Mantzoros C. Obesity as a Disease. Med Clin North Am [Internet]. 2018; 102 (1): 13–33. Available from: https://doi.org/10.1016/j.mcna.2017.08.004
[46]	Pranata R, Lim MA, Yonas E, Vania R, Lukito AA, Siswanto BB, et al. Body mass index and outcome in patients with COVID-19: A dose – response meta-analysis. Diabetes Metab [Internet]. 2020; 1–9. Available from: https://doi.org/10.1016/j.diabet.2020.07.005
[47]	Petrova D, Salamanca-Fernández E, Rodríguez Barranco M, Navarro Pérez P, Jiménez Moleón JJ, Sánchez MJ. Obesity as a risk factor in COVID-19: Possible mechanisms and implications. Aten Primaria [Internet]. 2020; 52 (7): 496-500. Available from: https://doi.org/10.1016/j.aprim.2020.05.003
[48]	Velázquez LC. COVID-19: a challenge for global science. An Acad Ciencias Cuba. 2020; 10 (2): 763.
[49]	Lázaro Díaz-Rodríguez Y, Amado Quintana-López L. “COVID-19. From pathogenesis to high mortality in the elderly and with comorbidities. " Rev Habanera Medical Sciences [Internet]. 2020 [cited 2021 Mar 26]; 19. Available from: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3531
[50]	Rico J, Daza R, Galvis N, Martínez V, Franco E, López J, et al. Obesity and Covid-19. Arch Medi. 2020; 16 (4): 1–5.
[51]	Salinas-Aguirre JE, Sánchez-García C, Rodríguez-Sanchez R, Rodríguez-Muñoz L, Díaz-Castaño A, Bernal-Gómez R. Clinical characteristics and comorbidities associated with mortality in patients with COVID-19 in Coahuila (Mexico). Rev Clínica Española. 2021; (1): 6–10.

Cite This Article

Plain Text BibTeX RIS

APA Style

Rosa Elvira Minchala Urgilés, Anabel Estefanía Arce Prieto, Andrés Alexis Ramírez Coronel, Lilia Romero Sacoto, Fanny González León, et al. (2021). Obesity as a Risk Factor Against COVID-19. Science Journal of Clinical Medicine, 10(2), 30-37. https://doi.org/10.11648/j.sjcm.20211002.13

Copy | Download

ACS Style

Rosa Elvira Minchala Urgilés; Anabel Estefanía Arce Prieto; Andrés Alexis Ramírez Coronel; Lilia Romero Sacoto; Fanny González León, et al. Obesity as a Risk Factor Against COVID-19. Sci. J. Clin. Med. 2021, 10(2), 30-37. doi: 10.11648/j.sjcm.20211002.13

Copy | Download

AMA Style

Rosa Elvira Minchala Urgilés, Anabel Estefanía Arce Prieto, Andrés Alexis Ramírez Coronel, Lilia Romero Sacoto, Fanny González León, et al. Obesity as a Risk Factor Against COVID-19. Sci J Clin Med. 2021;10(2):30-37. doi: 10.11648/j.sjcm.20211002.13

Copy | Download

@article{10.11648/j.sjcm.20211002.13,
  author = {Rosa Elvira Minchala Urgilés and Anabel Estefanía Arce Prieto and Andrés Alexis Ramírez Coronel and Lilia Romero Sacoto and Fanny González León and María De Los Ángeles Estrella-González and Pedro Carlos Martínez-Suárez},
  title = {Obesity as a Risk Factor Against COVID-19},
  journal = {Science Journal of Clinical Medicine},
  volume = {10},
  number = {2},
  pages = {30-37},
  doi = {10.11648/j.sjcm.20211002.13},
  url = {https://doi.org/10.11648/j.sjcm.20211002.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjcm.20211002.13},
  abstract = {In late 2019, in Wuhan City, China, SARS-CoV2 was identified as the cause of an outbreak of acute respiratory illness called COVID-19 representing its most frequent lethal complication. Objective: To analyze, by means of a literature review, obesity as a risk factor for COVID-19. Methodology: A systematic review of the literature was carried out in scientific databases such as: Latin American and Caribbean Health Sciences Literature (LILACS); Virtual Health Library (VHL): Wiley Online Library and Medical Literature Analysis and Retrieval System Online (MEDLINE), Scielo, Scopus. The search terms included the study variables. Results: According to the analysis of 51 articles, it was determined that obese, male and elderly patients are the profile most prone to present respiratory system failures associated with COVID-19. Their pictures are aggravated by immunological and hormonal physiopathology typical of obesity; in addition, comorbidity in which there is diabetes, hypertension, cardiovascular diseases and obstructive pulmonary disease aggravates the picture of COVID-19 in obese patients. Conclusions: The presence of obesity is indeed a risk factor against COVID-19 infection, since it increases the possibility of suffering severe respiratory conditions.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Obesity as a Risk Factor Against COVID-19
AU  - Rosa Elvira Minchala Urgilés
AU  - Anabel Estefanía Arce Prieto
AU  - Andrés Alexis Ramírez Coronel
AU  - Lilia Romero Sacoto
AU  - Fanny González León
AU  - María De Los Ángeles Estrella-González
AU  - Pedro Carlos Martínez-Suárez
Y1  - 2021/05/31
PY  - 2021
N1  - https://doi.org/10.11648/j.sjcm.20211002.13
DO  - 10.11648/j.sjcm.20211002.13
T2  - Science Journal of Clinical Medicine
JF  - Science Journal of Clinical Medicine
JO  - Science Journal of Clinical Medicine
SP  - 30
EP  - 37
PB  - Science Publishing Group
SN  - 2327-2732
UR  - https://doi.org/10.11648/j.sjcm.20211002.13
AB  - In late 2019, in Wuhan City, China, SARS-CoV2 was identified as the cause of an outbreak of acute respiratory illness called COVID-19 representing its most frequent lethal complication. Objective: To analyze, by means of a literature review, obesity as a risk factor for COVID-19. Methodology: A systematic review of the literature was carried out in scientific databases such as: Latin American and Caribbean Health Sciences Literature (LILACS); Virtual Health Library (VHL): Wiley Online Library and Medical Literature Analysis and Retrieval System Online (MEDLINE), Scielo, Scopus. The search terms included the study variables. Results: According to the analysis of 51 articles, it was determined that obese, male and elderly patients are the profile most prone to present respiratory system failures associated with COVID-19. Their pictures are aggravated by immunological and hormonal physiopathology typical of obesity; in addition, comorbidity in which there is diabetes, hypertension, cardiovascular diseases and obstructive pulmonary disease aggravates the picture of COVID-19 in obese patients. Conclusions: The presence of obesity is indeed a risk factor against COVID-19 infection, since it increases the possibility of suffering severe respiratory conditions.
VL  - 10
IS  - 2
ER  -

Copy | Download

Author Information

Rosa Elvira Minchala Urgilés

Faculty of Nursing, Catholic University of Cuenca, Azogues, Ecuador
Anabel Estefanía Arce Prieto

Faculty of Nursing, Catholic University of Cuenca, Azogues, Ecuador
Andrés Alexis Ramírez Coronel

Faculty of Nursing, Catholic University of Cuenca, Azogues, Ecuador
Lilia Romero Sacoto

Faculty of Nursing, Catholic University of Cuenca, Azogues, Ecuador
Fanny González León

Faculty of Nursing, Catholic University of Cuenca, Azogues, Ecuador
María De Los Ángeles Estrella-González
Pedro Carlos Martínez-Suárez

Laboratory of Psychometry and Cognitive Neurosciences of the Center for Research, Innovation and Technology Transfer, Catholic University of Cuenca, Cuenca, Ecuador

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Rosa Elvira Minchala Urgilés, Anabel Estefanía Arce Prieto, Andrés Alexis Ramírez Coronel, Lilia Romero Sacoto, Fanny González León, et al. (2021). Obesity as a Risk Factor Against COVID-19. Science Journal of Clinical Medicine, 10(2), 30-37. https://doi.org/10.11648/j.sjcm.20211002.13

Copy | Download

ACS Style

Rosa Elvira Minchala Urgilés; Anabel Estefanía Arce Prieto; Andrés Alexis Ramírez Coronel; Lilia Romero Sacoto; Fanny González León, et al. Obesity as a Risk Factor Against COVID-19. Sci. J. Clin. Med. 2021, 10(2), 30-37. doi: 10.11648/j.sjcm.20211002.13

Copy | Download

AMA Style

Rosa Elvira Minchala Urgilés, Anabel Estefanía Arce Prieto, Andrés Alexis Ramírez Coronel, Lilia Romero Sacoto, Fanny González León, et al. Obesity as a Risk Factor Against COVID-19. Sci J Clin Med. 2021;10(2):30-37. doi: 10.11648/j.sjcm.20211002.13

Copy | Download

@article{10.11648/j.sjcm.20211002.13,
  author = {Rosa Elvira Minchala Urgilés and Anabel Estefanía Arce Prieto and Andrés Alexis Ramírez Coronel and Lilia Romero Sacoto and Fanny González León and María De Los Ángeles Estrella-González and Pedro Carlos Martínez-Suárez},
  title = {Obesity as a Risk Factor Against COVID-19},
  journal = {Science Journal of Clinical Medicine},
  volume = {10},
  number = {2},
  pages = {30-37},
  doi = {10.11648/j.sjcm.20211002.13},
  url = {https://doi.org/10.11648/j.sjcm.20211002.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjcm.20211002.13},
  abstract = {In late 2019, in Wuhan City, China, SARS-CoV2 was identified as the cause of an outbreak of acute respiratory illness called COVID-19 representing its most frequent lethal complication. Objective: To analyze, by means of a literature review, obesity as a risk factor for COVID-19. Methodology: A systematic review of the literature was carried out in scientific databases such as: Latin American and Caribbean Health Sciences Literature (LILACS); Virtual Health Library (VHL): Wiley Online Library and Medical Literature Analysis and Retrieval System Online (MEDLINE), Scielo, Scopus. The search terms included the study variables. Results: According to the analysis of 51 articles, it was determined that obese, male and elderly patients are the profile most prone to present respiratory system failures associated with COVID-19. Their pictures are aggravated by immunological and hormonal physiopathology typical of obesity; in addition, comorbidity in which there is diabetes, hypertension, cardiovascular diseases and obstructive pulmonary disease aggravates the picture of COVID-19 in obese patients. Conclusions: The presence of obesity is indeed a risk factor against COVID-19 infection, since it increases the possibility of suffering severe respiratory conditions.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Obesity as a Risk Factor Against COVID-19
AU  - Rosa Elvira Minchala Urgilés
AU  - Anabel Estefanía Arce Prieto
AU  - Andrés Alexis Ramírez Coronel
AU  - Lilia Romero Sacoto
AU  - Fanny González León
AU  - María De Los Ángeles Estrella-González
AU  - Pedro Carlos Martínez-Suárez
Y1  - 2021/05/31
PY  - 2021
N1  - https://doi.org/10.11648/j.sjcm.20211002.13
DO  - 10.11648/j.sjcm.20211002.13
T2  - Science Journal of Clinical Medicine
JF  - Science Journal of Clinical Medicine
JO  - Science Journal of Clinical Medicine
SP  - 30
EP  - 37
PB  - Science Publishing Group
SN  - 2327-2732
UR  - https://doi.org/10.11648/j.sjcm.20211002.13
AB  - In late 2019, in Wuhan City, China, SARS-CoV2 was identified as the cause of an outbreak of acute respiratory illness called COVID-19 representing its most frequent lethal complication. Objective: To analyze, by means of a literature review, obesity as a risk factor for COVID-19. Methodology: A systematic review of the literature was carried out in scientific databases such as: Latin American and Caribbean Health Sciences Literature (LILACS); Virtual Health Library (VHL): Wiley Online Library and Medical Literature Analysis and Retrieval System Online (MEDLINE), Scielo, Scopus. The search terms included the study variables. Results: According to the analysis of 51 articles, it was determined that obese, male and elderly patients are the profile most prone to present respiratory system failures associated with COVID-19. Their pictures are aggravated by immunological and hormonal physiopathology typical of obesity; in addition, comorbidity in which there is diabetes, hypertension, cardiovascular diseases and obstructive pulmonary disease aggravates the picture of COVID-19 in obese patients. Conclusions: The presence of obesity is indeed a risk factor against COVID-19 infection, since it increases the possibility of suffering severe respiratory conditions.
VL  - 10
IS  - 2
ER  -

Copy | Download